Celularity Inc. (NASDAQ: CELU) kicked off on May 22, 2023, at the price of $0.749, up 3.89% from the previous trading day. During the day, the shares moved up to $0.758 and dropped to $0.5803 before settling in for the closing price of $0.65. Over the past 52 weeks, CELU has traded in a range of $0.40-$11.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 106.30%. With a float of $60.06 million, this company’s outstanding shares have now reached $146.26 million.
Let’s determine the extent of company efficiency that accounts for 225 employees. In terms of profitability, gross margin is -61.90, operating margin of -824.85, and the pretax margin is +79.03.
Celularity Inc. (CELU) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Celularity Inc. is 6.50%, while institutional ownership is 24.40%. The most recent insider transaction that took place on Nov 30, was worth 17,175. In this transaction Chief Executive Officer of this company bought 10,000 shares at a rate of $1.72, taking the stock ownership to the 8,074,996 shares. Before that another transaction happened on Nov 29, when Company’s Chief Executive Officer bought 40,000 for $1.71, making the entire transaction worth $68,400. This insider now owns 8,064,996 shares in total.
Celularity Inc. (CELU) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/29/2022, the organization reported $0.03 earnings per share (EPS), higher than consensus estimate (set at -$0.26) by $0.29. This company achieved a net margin of +78.95 while generating a return on equity of 9.51. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 106.30% per share during the next fiscal year.
Celularity Inc. (NASDAQ: CELU) Trading Performance Indicators
Take a look at Celularity Inc.’s (CELU) current performance indicators. Last quarter, stock had a quick ratio of 0.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.00, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.73 in one year’s time.
Technical Analysis of Celularity Inc. (CELU)
Looking closely at Celularity Inc. (NASDAQ: CELU), its last 5-days average volume was 1.12 million, which is a jump from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 91.23%. Additionally, its Average True Range was 0.08.
During the past 100 days, Celularity Inc.’s (CELU) raw stochastic average was set at 27.79%, which indicates a significant decrease from 76.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.84% in the past 14 days, which was higher than the 103.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6064, while its 200-day Moving Average is $1.4784. However, in the short run, Celularity Inc.’s stock first resistance to watch stands at $0.7620. Second resistance stands at $0.8488. The third major resistance level sits at $0.9397. If the price goes on to break the first support level at $0.5843, it is likely to go to the next support level at $0.4934. Now, if the price goes above the second support level, the third support stands at $0.4066.
Celularity Inc. (NASDAQ: CELU) Key Stats
The company with the Market Capitalisation of 105.94 million has total of 165,029K Shares Outstanding. Its annual sales at the moment are 17,980 K in contrast with the sum of 14,190 K annual income. Company’s last quarter sales were recorded 4,130 K and last quarter income was 24,430 K.
